Status:
ACTIVE_NOT_RECRUITING
BioDulse II: The Effect of an Irish Seaweed Protein Extract on Glucose Control in Adults With Type 2 Diabetes
Lead Sponsor:
University of Limerick
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18-67 years
Phase:
NA
Brief Summary
Co-ingesting protein with carbohydrate is an effective way to improve postprandial glucose handling. The investigators have isolated and identified a bioactive protein extracted from seaweed. The inve...
Eligibility Criteria
Inclusion
- Aged 18-67
Exclusion
- Terminal disease
- Exclusively receiving enteral or parenteral nutrition
- Any conditions/anomalies that are contraindications to bioelectrical impedance analysis as per institutional risk assessment and standard operating procedures
- Past medical history of cancer, neurological, kidney, pulmonary, digestive (Coeliac disease), thyroidal disease, cognitive impairment
Key Trial Info
Start Date :
August 7 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2031
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05986253
Start Date
August 7 2023
End Date
December 31 2031
Last Update
April 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Limerick
Limerick, Ireland, V94 T9PX